RIVER TAMMETTA: Open Payments
NPI 1689387631 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 11 payments from 6 companies in 2025. Trend: 2023 $1,349 · 2024 $1,943 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| ABBVIE INC. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Alkermes, Inc. | 1 | $23 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
Products named: FANAPT, EPKINLY, AUSTEDO XR, CAPLYTA, VRAYLAR, ARISTADA, DAXXIFY.
Industry payments across AZ — which companies pay providers there.
